Description
Revised International Staging System (R2-ISS) is a validated prognostic tool for multiple myeloma that combines:
-Traditional ISS criteria (β2-microglobulin and albumin)
-High-risk chromosomal abnormalities
-Serum lactate dehydrogenase (LDH)
This calculator provides accurate staging based on the latest clinical guidelines.